Hangzhou Leap Chem Co., Ltd. yog ib qho ntawm cov tuam txhab tshaj lij thiab cov neeg muag khoom ntawm 4-(4-bromo-2-fluoroanilino)-7-hydroxy-6-methoxyquinazoline 丨cas 196603-96-0 hauv Suav teb. Txais tos rau cov lag luam wholesale bulk zoo tshuaj cov khoom ntawm kev sis tw nqi los ntawm peb lub hoobkas. Yog tias koj muaj lus nug txog kev pabcuam kev cai, thov koj xa email rau peb.
Specifications
| Qhov tsos: | tawm -dawb mus rau lub teeb daj daj |
| Kev ntsuam xyuas: | 99% min |
| Loss ntawm ziab: | 0.1% max |
| Related impurity: | 0.1% max |
| Ib qho impurity: | 0.05% max |
4-(4-Bromo-2-fluoroanilino)-7-hydroxy-6-methoxyquinazoline yog quinazoline-based heterocyclic compound feem ntau yog siv los ua tshuaj nruab nrab hauv kev tshawb fawb oncology. Nws yog ib qho tseem ceeb tshwj xeeb hauv kev sib txuas ntawm cov tshuaj tiv thaiv kab mob Vandetanib thiab lwm yam VEGFR / EGFR tyrosine kinase inhibitors, nrog rau PET imaging agents rau VEGFR2-targeted cancer diagnostics.
Cim npe nrov: 4-(4-bromo-2-fluoroanilino)-7-hydroxy-6-methoxyquinazoline 丨cas 196603-96-0, Tuam Tshoj 4-(4-bromo-2-fluoroanilino)-7-hydroxy-6-methoxyquinazoline 丨cas 196603-96-0 manufacturers, hoobkas
